- Home
- NTHI vs TYGO Comparison
NTHI vs TYGO Comparison
Compare NTHI & TYGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NTHI | TYGO |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.5M | 129.0M |
| IPO Year | 2023 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NTHI | TYGO |
|---|---|---|
| Price | $4.23 | $1.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $15.00 | $6.00 |
| AVG Volume (30 Days) | 180.6K | ★ 1.8M |
| Earning Date | 05-19-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.12 |
| EPS | N/A | ★ 0.01 |
| Revenue | $39,990.00 | ★ $103,536,000.00 |
| Revenue This Year | N/A | $30.78 |
| Revenue Next Year | N/A | $21.68 |
| P/E Ratio | ★ N/A | $122.00 |
| Revenue Growth | N/A | ★ 91.68 |
| 52 Week Low | $3.01 | $0.93 |
| 52 Week High | $12.99 | $5.33 |
Technical Indicators
Market Signals| Indicator | NTHI | TYGO |
|---|---|---|
| Relative Strength Index (RSI) | 54.63 | 31.48 |
| Support Level | $3.01 | $0.93 |
| Resistance Level | $4.59 | $2.03 |
| Average True Range (ATR) | 0.44 | 0.15 |
| MACD | 0.10 | -0.00 |
| Stochastic Oscillator | 58.70 | 21.47 |
Price Performance
Historical ComparisonAbout NTHI NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
About TYGO Tigo Energy Inc.
Tigo Energy Inc provides solar and energy storage solutions, including module level power electronics (MLPE) designed to maximize the energy output of individual solar modules, delivering more energy, active management, and enhanced safety for utility, commercial, and residential solar arrays. By combining its MLPE and solar optimizer technology with intelligent, cloud-based software capabilities, the Company enables developed energy monitoring, system diagnostics, and real-time control. Geographically the company generates revenue from EMEA, Americas, and APAC.